Hepatitis B and C Prevention, Screening, and Diagnostic Services at HIV Treatment Sites: International Epidemiology Databases to Evaluate AIDS.
Journal of acquired immune deficiency syndromes (1999)·
- DOI
- 10.1097/qai.0000000000003896
- PMID
- 42086340
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Publisher unavailable
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.
Structured evidence summary
Research question
The study examined the availability of HBV and HCV prevention, screening, and diagnostic services at HIV treatment sites participating in a multinational network.
Study design
Cross-sectional survey of HIV treatment centers across 7 IeDEA regions using 2023 service-delivery data, with multivariable logistic regression to test associations between site characteristics and service availability.
Population and setting
A total of 204 HIV treatment sites within the IeDEA network across 7 global regions, including sites serving predominantly urban or rural populations.
Main findings
On-site HBV vaccination was reported at 67.7% of sites; HBV and HCV screening at enrollment at 72.1% and 50%, respectively; and on-site HBsAg, HBV DNA, HCV antibody, and HCV RNA testing at 77%, 47.6%, 61.8%, and 44.6%, respectively. Sites serving predominantly rural (vs. urban) populations had lower odds of on-site HBV DNA, HCV antibody, and HCV RNA testing.
Public-health relevance
Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.
Important limitations
This summary is limited to the supplied single-article abstract/metadata and requires the original paper for decision-grade interpretation; explicit limitations beyond the cross-sectional, self-reported survey design were not provided in the abstract.
GIDS interpretation
The paper is catalogued under hepatitis and HIV-related topics including diagnostics, treatment, and vaccination, making it discoverable for editors seeking evidence on hepatitis service integration in HIV care settings; no connection to a live surveillance signal is made.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 15 auditable classifier relationships to diseases, places, topics, and study design.